However, the resulting drugs and the process by which they are made aren't clinically tested, which is why the resulting drugs are not FDA-approved.They are also not subject to the same supply-chain tracking as FDA-approved drugs are
I can now walk past a piece of cake no problem
33 In a randomized, double-blind, placebo-controlled trial involving patients with MASH, treatment with NGM282 (an engineered FGF19 analog) for 12 weeks led to rapid and significant reductions in liver fat content, ALT, AST, and serum markers of fibrogenesis
Dissolution: Remove the syringe
doi: 10.1016/j.semcdb.2012.12.002 18 DoyleMEPremathilakeHUYaoQMazucantiCHEganJM
However, the mechanisms by which SGLT2 inhibitors exert these benefits beyond glucose-lowering are not fully understood